Esmya revenues fall short of expectations
…regulator acted likewise, whereas the FDA refused to approve the drug, citing safety issues and requesting more information for further decisions. In an interview with Vilaggazdasag, Mr Orban admitted that it is technically impossible that the FDA could register Esmya in the next18 months.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)